Safety and tolerability of biodegradable balloon spacers in patients undergoing radiotherapy for organ-confined prostate cancer

被引:0
|
作者
Topazio, Luca [1 ]
Narcisi, Federico [1 ]
Tana, Fabio [2 ]
Ciotta, Cosimo [2 ]
Iossa, Vincenzo [2 ]
Perna, Pasquale [2 ]
Chiaramonti, Francesco [2 ]
Romantini, Federico [1 ]
机构
[1] ASL Teramo, UOC Urol, Teramo, Italy
[2] Univ Aquila, Dept Life Hlth & Environm Sci, UOC Urol, PO Mazzini, Teramo, Italy
关键词
Prostate cancer; Spacer; Radiotherapy; Hypo-fractionated radiotherapy; RADIATION-THERAPY;
D O I
10.4081/aiua.2023.11156
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Radiotherapy is a common treatment for prostate cancer, and can be administered in various ways, including 3D conformal radio-therapy (3DCRT), intensity-modulated radiotherapy (IMRT) and hypo-fractionated radiation therapy. During treatment the gastrointestinal tract may be exposed to radiation and the rectal wall may be exposed to high doses of ionizing radiation, which can lead to rectal bleeding, ulcers or fistulas, and an increased risk of rectum cancer. Various strategies to minimize these complications have been developed in the last decade; one of the most promising is to use a rectal balloon to fixate the prostate gland during treatment or to inject biodegradable spacers between the prostate and rectum to reduce the rectal dose of radiation. Aim of our paper is to evaluate the safety and tolerability of spacers implantation. Materials and methods: From January 2021 to June 2022 all patients with a diagnosis of prostate cancer with unfavor-able/intermediate risk -poor prognosis and programmed hypo -fractionated radiation therapy were enrolled. In all patients biodegradable balloons spacers were placed posteriorly to the prostate to increase the separation between prostate and rectum. The duration of the procedure, observa-tion time, the appearance of early and late complications and their severity (according to Charlson comorbidity index) and tolerability of the device were recorded at the time of positioning and after 10 days. Results: 25 patients were enrolled in our study. Two patients (8%) underwent acute urine retention resolved with catheteri-zation and one patient (4%) developed a mild perineal hematoma that did not require any treatment. As regards late complications 1 patient (4%) developed hyperpyrexia (> 38 & DEG;C) the day after the procedure requiring continuation of antibiotic regimen. At T1 visit we recorded no medium-high grade complications. As for the tolerability of the device, it was optimal with no perineal discomfort or alterations of bowel function. Conclusions: Biodegradable balloon spacers appears to be safe and well tolerated and its positioning does not present any technical difficulties or risks of major complications.
引用
收藏
页码:35 / 38
页数:4
相关论文
共 50 条
  • [31] Stereotactic body radiotherapy for treatment of organ-confined prostate cancer: Efficacy and quality of life at 4 years
    Katz, A. J.
    Santoro, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [32] Prediction of potentially insignificant prostate cancer in men undergoing radical prostatectomy for clinically organ-confined disease
    Miyake, H
    Sakai, I
    Harada, K
    Hara, I
    Eto, H
    INTERNATIONAL JOURNAL OF UROLOGY, 2005, 12 (03) : 270 - 274
  • [33] Erectile function following external beam radiotherapy for clinically organ-confined or locally advanced prostate cancer
    Hisasue, S
    Kato, R
    Takahashi, A
    Masumori, N
    Itoh, N
    Miyao, N
    Takatsuka, K
    Yanase, M
    Oouchi, A
    Hareyama, M
    Tsukamnoto, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (05) : 269 - 273
  • [34] INITIAL TREATMENT COSTS OF ORGAN-CONFINED PROSTATE CANCER: A GENERAL PERSPECTIVE
    Kommu, Sashi S.
    Eden, Christopher G.
    Luscombe, Christopher J.
    Golash, Anurag
    Persad, Rajendra A.
    BJU INTERNATIONAL, 2011, 107 (01) : 1 - 3
  • [35] Outcomes and Predictors of Organ-Confined Prostate Cancer Treated with Radiation Therapy
    Supit, W.
    Mochtar, C.
    Santoso, R.
    Umbas, R.
    UROLOGY, 2012, 80 (03) : S302 - S303
  • [36] The possible role of chromogranin A as a prognostic factor in organ-confined prostate cancer
    Grimaldi, F.
    Valotto, C.
    Barbina, G.
    Visentini, D.
    Trianni, A.
    Cerruto, M. A.
    Zattoni, F.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2006, 21 (04): : 229 - 234
  • [37] PSA kinetics following primary focal cryotherapy (hemiablation) in organ-confined prostate cancer patients
    Michael Kongnyuy
    Shahidul Islam
    Alfred K. Mbah
    Daniel M. Halpern
    Glenn T. Werneburg
    Kaitlin E. Kosinski
    Connie Chen
    David J. Habibian
    Jeffrey T. Schiff
    Anthony T. Corcoran
    Aaron E. Katz
    World Journal of Urology, 2018, 36 : 209 - 213
  • [38] Noninvasive treatment of organ-confined prostate cancer in elderly patients-results of the HAROW study
    Herder, Jan
    Boedefeld, Edith A.
    Weissbach, Lothar
    UROLOGE, 2020, 59 (04): : 450 - 460
  • [39] PSA kinetics following primary focal cryotherapy (hemiablation) in organ-confined prostate cancer patients
    Kongnyuy, Michael
    Islam, Shahidul
    Mbah, Alfred K.
    Halpern, Daniel M.
    Werneburg, Glenn T.
    Kosinski, Kaitlin E.
    Chen, Connie
    Habibian, David J.
    Schiff, Jeffrey T.
    Corcoran, Anthony T.
    Katz, Aaron E.
    WORLD JOURNAL OF UROLOGY, 2018, 36 (02) : 209 - 213
  • [40] Prognostic Role of Perineural Invasion in 239 Consecutive Patients with Pathologically Organ-Confined Prostate Cancer
    Masieri, Lorenzo
    Lanciotti, Michele
    Nesi, Gabriella
    Lanzi, Federico
    Tosi, Nicola
    Minervini, Andrea
    Lapini, Alberto
    Carini, Marco
    Serni, Sergio
    UROLOGIA INTERNATIONALIS, 2010, 85 (04) : 396 - 400